InvestorsHub Logo
Followers 0
Posts 9
Boards Moderated 0
Alias Born 02/08/2012

Re: None

Thursday, 01/30/2014 8:14:16 AM

Thursday, January 30, 2014 8:14:16 AM

Post# of 1673
CEO Announces Plans to Conduct a Phase 2A Study for Type 1 Diabetes

CEO Nadav Kidron. "Following on the results from this type 2 diabetes study we are gearing up to start a multi-center Phase 2b study later this year. We are also excited about the potential of this drug for type 1 diabetes and plan to initiate a Phase 2a FDA study for this indication in the near term."

http://finance.yahoo.com/news/oramed-announces-successful-fda-phase-090000076.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ORMP News